Antifungal drugs Market size valued at USD 11 billion in 2021 and expected to reach USD 14.09 billion by 2028, at a CAGR of 3.60% during the forecast period 2022 to 2028. Antifungal drugs are used in the treatment of various fungal infections, by killing the fungal cell by cell breaking and leak out the contents of cell and leads to the cell death. They also act by preventing the cell growth with minimal toxic adverse effects to the body. Fungal infections occur due to unhygienic, unclean, and dampness in the environment. Fungal infections mainly caused by the microorganisms entering into the epithelial tissue. Fungi utilizes the keratin and cause infection of the hair, skin, and nail Anti- fungal drugs enables to treat fungal infections like athlete’s foot, ringworm, vaginal thrush, and nail infection. Systemic fungal infections are caused due to inhalation or indigestion of fungal spores and cause fungal pneumonia. The global antifungal drugs market is in blooming stage, several local and international players are actively involved in the development of antifungal drugs. The collaboration of government organizations for the increase in the awareness about fungal infections is expected to unlock the potential of antifungal drugs market. For instance, In November 2013, the CDC entered into a collaborative agreement with the National Health Ministry to enhance the treatment rates of communicable diseases in emerging countries, such as Brazil and India. Major acquisitions and collaborations among companies to commercialize antifungal drugs, mergers, launching of new products, and product approvals from various drug regulatory bodies such as U.S. FDA and EMEA enable increase the global antifungal drugs market growth. For instance, in October 2009, Mylan inks licensing deal with Pfizer to start selling a U.S. generic version of Pfizer’s Vfend antifungal drug. The increase in the prevalence of fungal infections also boosts the antifungal drugs market growth. According to Centres for Disease Control and Prevention (CDC), around one million people get infected worldwide by cryptococcal meningitis, which is a brain infection caused by fungus Cryptococcus and it subsequently leads to 625,000 deaths.